Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$49.90 – $73.18
57% from low
Exchange
OTC Link
ADRC
Borrow rate
10.42%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.39B | $14.37B | $14.01B | $14.95B | $17.55B | $17.90B | $513.7M | $4.16B |
| Cost of revenue | $6.13B | $6.42B | $6.16B | $6.33B | $7.96B | $8.18B | $271.2M | $1.92B |
| Gross profit | $8.26B | $7.95B | $7.85B | $8.62B | $9.58B | $9.72B | $242.5M | $2.24B |
| Gross margin | 57.4% | 55.3% | 56.0% | 57.7% | 54.6% | 54.3% | 47.2% | 53.9% |
| R&D | $1.86B | $1.97B | $1.94B | $2.01B | $1.62B | $2.02B | $55.4M | −$55.7M |
| Operating income | $4.07B | $4.04B | $3.65B | $4.07B | $4.56B | $3.98B | $663.7M | $882.6M |
| EBITDA | $5.30B | $5.07B | $4.82B | $5.40B | $6.12B | $5.47B | $1.08B | $1.39B |
| Net income | $3.23B | $3.15B | $2.83B | $3.15B | $3.68B | $3.02B | $41.0M | $583.6M |
| Net margin | 22.4% | 21.9% | 20.2% | 21.0% | 20.9% | 16.9% | 8.0% | 14.0% |
| EPS (diluted) | 11.03 | 11.01 | 10.02 | 11.23 | 13.19 | 1.46 | 0.15 | 1.25 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $33.8B | $15.32 | $15.00–$15.57 | 2 |
| 2027 | $36.3B | $16.98 | $16.52–$17.38 | 2 |
| 2028 | $38.9B | $18.89 | $18.33–$19.44 | 1 |
| 2029 | $41.9B | $22.42 | $21.75–$23.06 | 1 |
Forward consensus · source: Financial Modeling Prep
NOVONESIS B UNSP/ADR
No one on the platform currently holds NVZMY.
No tracked institution reports a position in NVZMY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-25 | $0.6533 | 2026-04-10 |
| 2025-09-02 | $0.3504 | 2025-09-11 |
| 2025-04-07 | $0.6136 | 2025-04-23 |
| 2024-09-09 | $0.2949 | 2024-09-18 |
| 2024-05-01 | $0.2883 | 2024-05-20 |
| 2023-10-20 | $0.5938 | 2023-11-01 |
No one on the platform has traded NVZMY yet.
| $36.8B |
| — |
| GVDNYGivaudan S.A. | $84.47 | -0.11% | $39.0B | — |
| PTPIFPT. Chandra Asri Petrochemical Tbk | $0.53 | +0.00% | $45.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 93.7× earnings vs its 33.3× historical median P/E.
Fair value ≈ $22.46 · price $63.24 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.